# Punjab drug case sparks political accountability debate

> Punjab’s drug problem and political accountability resurface as SAD leader faces chargesheet over alleged ₹736 crore transactions.
- Title: Punjab drug case sparks political accountability debate · mint
- Summary: Punjab’s drug problem and political accountability resurface as SAD leader faces chargesheet over alleged ₹736 crore transactions. Punjab’s AAP party links…
- Keywords: punjab, drug trafficking, political accountability, sad, bikram singh majithia, punjab cm mann, aam aadmi party, punjab assembly election, 2027, news, india, drug
- Source: mint — https://livemint.com/focus/majithia-case-renews-debate-on-punjab-s-drug-problem-and-political-accountability-11793186346721.html
- Author: Focus
- Published: 2026-10-28T11:21:17+00:00
- Read time: 1 min
- Topics: punjab, drug trafficking, political accountability, sad, bikram singh majithia, punjab cm mann, aam aadmi party, punjab assembly election, 2027, news, india
## Majithia chargesheet
A chargesheet against SAD leader Bikram Singh Majithia has revived Punjab’s debate over drugs, political accountability and election-year claims.
## Alleged transactions
The chargesheet includes transactions worth ₹ 736 crore, which have not been established as criminal proceeds by a court.
## Political response
AAP has cited allegations involving companies associated with Majithia as evidence of the need for action against influential individuals.
## SAD-BJP coalition record
The party alleges drug trafficking networks were not dealt with effectively during the SAD-BJP coalition government from 2007 to 2017.
## Judicial scrutiny
The Punjab Vigilance Bureau filed a roughly 40,000-page chargesheet against Majithia in August 2025, according to media reports.
## Election context
The case renews questions ahead of Punjab’s 2027 assembly election, when parties face scrutiny over drug policy records.
## Key takeaway

Punjab’s AAP party links drug trafficking to SAD-BJP coalition’s governance from 2007-2017, demanding accountability for drug-related issues.